AVITA Medical to Participate in Lake Street's 8th Annual Best Ideas Growth (BIG8) Conference
AVITA Medical Inc (NASDAQ:RCEL) A Bull Case Theory
TD Cowen Maintains Avita Medical(RCEL.US) With Buy Rating, Maintains Target Price $15
TD Cowen analyst Josh Jennings maintains $Avita Medical(RCEL.US)$ with a buy rating, and maintains the target price at $15.According to TipRanks data, the analyst has a success rate of 54.4% and a
Why Avita Medical, Car Group, Dicker Data, and JB Hi-Fi Shares Are Soaring Today
Avita Medical Target Price Cut 19% to A$4.56/Share by Morgans>AVH.AU
Avita Medical Upgraded to Buy From Hold by Bell Potter